EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Circulating non-coding RNA biomarkers of endocrine tumours

Henriett Butz, Attila Patócs, Peter Igaz

Nature Reviews Endocrinology · 2024-10 · 20 (10) · 600-614

DOI: 10.1038/s41574-024-01005-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Reviews Endocrinology, online erschienen am 17.06.2024. Verfasst von Henriett Butz und 2 weiteren Autor:innen. Beteiligte Einrichtung: HUN-REN-SU Hereditary Tumours Research Group, Budapest, Hungary. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Endocrine Gland Neoplasms, RNA, Untranslated. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 149 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating non-coding RNA (ncRNA) molecules are being investigated as biomarkers of malignancy, prognosis and follow-up in several neoplasms, including endocrine tumours of the pituitary, parathyroid, pancreas and adrenal glands. Most of these tumours are classified as neuroendocrine neoplasms (comprised of neuroendocrine tumours and neuroendocrine carcinomas) and include tumours of variable aggressivity. We consider them together here in this Review owing to similarities in their clinical presentation, pathomechanism and genetic background. No preoperative biomarkers of malignancy are available for several forms of these endocrine tumours. Moreover, biomarkers are also needed for the follow-up of tumour progression (especially in hormonally inactive tumours), prognosis and treatment efficacy monitoring. Circulating blood-borne ncRNAs show promising utility as biomarkers. These ncRNAs, including microRNAs, long non-coding RNAs and circular RNAs, are involved in several aspects of gene expression regulation, and their stability and tissue-specific expression could make them ideal biomarkers. However, no circulating ncRNA biomarkers have yet been introduced into routine clinical practice, which is mostly owing to methodological and standardization problems. In this Review, following a brief synopsis of these endocrine tumours and the biology of ncRNAs, the major research findings, pathomechanisms and methodological questions are discussed along with an outlook for future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorEndocrine Gland NeoplasmsRNA, UntranslatedHumansNeuroendocrine TumorsRNA, Long NoncodingPrognosis

Substanzen

Biomarkers, TumorRNA, UntranslatedRNA, Long Noncoding

Autor:innen und Institutionen

  • HUN-REN-SU Hereditary Tumours Research Group, Budapest, Hungary.
  • Department of Molecular Genetics and the National Tumour Biology Laboratory, National Institute of Oncology, Budapest, Hungary.
  • Department of Laboratory Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Department of Endocrinology, Faculty of Medicine, Semmelweis University, Budapest, Hungary. igaz.peter@semmelweis.hu.
  • Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary. igaz.peter@semmelweis.hu.

Zitieren

APA

Butz, H., Patócs, A., & Igaz, P. (2024). Circulating non-coding RNA biomarkers of endocrine tumours. Nature Reviews Endocrinology, 20(10), 600-614. https://doi.org/10.1038/s41574-024-01005-8

Vancouver

Butz H, Patócs A, Igaz P. Circulating non-coding RNA biomarkers of endocrine tumours. Nature Reviews Endocrinology. 2024;20(10):600-614. doi:10.1038/s41574-024-01005-8

BibTeX
@article{Butz2024,
  author = {Butz, Henriett and Patócs, Attila and Igaz, Peter},
  title = {Circulating non-coding RNA biomarkers of endocrine tumours},
  journal = {Nature Reviews Endocrinology},
  year = {2024},
  volume = {20},
  number = {10},
  pages = {600--614},
  doi = {10.1038/s41574-024-01005-8}
}
Kostenlos starten →